Listen to Gynecologic Oncology

Editor’s choice: Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva

Editorial: Optimizing and harmonizing lymph node dissection and radiotherapy in advanced vulvar cancer

Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology

Featuring:  Dr Lilian T. Gien, MD, MSc, FRCSC, University of Toronto, Canada

Dr Brenna Swift, MD, FRCSC, MSc, MASc, University of Toronto, Canada

Dr Scott Glaser, MD, City of Hope, USA

Editor’s choice: Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists

Editorial: Who you gonna call?

Hosted by:
David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology

Featuring:
M. Dwight Chen, MD, Palo Alto Foundation Medical Group/Sutter Health
Connor C. Wang, MD, Northwestern University Feinberg School of Medicine
Emma Barber, MD, MS, Northwestern University Feinberg School of Medicine

Reviews: 2023 changes to FIGO endometrial cancer staging: Counterpoint; 2023 FIGO staging system for endometrial cancer: The evolution of the revolution

Editor’s Choice Paper:
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study

Editor’s Choice Paper: 
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers

Editorial:
The importance of family-focused care in the setting of advanced gynecological cancers

Hosted by:
Sean Dowdy, MD, Associate Editor of Gynecologic Oncology



Featuring:
Rachel A. Pozzar, PhD, RN, Dana Farber Cancer Institute and Harvard Medical School
Allison J. Applebaum, PhD, Caregivers Clinic, Memorial Sloan Kettering Cancer Center

Editor’s Choice Paper: 
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma

Editorial:
What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancer

Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology



Featuring:
Joyce Barlin, MD, Women’s Cancer Care Associates & Albany Medical College
Gretchen Glaser, MD, Mayo Clinic 
John Weroha, MD, Mayo Clinic

Editor’s Choice Paper: 
Use of a mobile health patient engagement technology improves perioperative outcomes in gynecologic oncology patients

Editorial:
How does mobile health engagement technology help gynecologic oncology patients recover from surgery, affect health equity, and impact healthcare costs?

Hosted by:
Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology



Featuring:
Teresa K.L. Boitano, MD, University of Alabama at Birmingham
Kevin M. Elias, MD, FACOG, FACS, Brigham and Women’s Hospital

Editor’s Choice Paper: 
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study

Hosted by:
Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology



Featuring:
Ane Gerda Z. Eriksson, MD, Oslo University Hospital, Norway
S. J. Kitson, MD, University of Manchester, UK

Editor’s Choice Paper: 
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer

Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology



Featuring:
Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center 

Editor’s Choice Paper: 
Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?

Editorial: Universal thromboprophylaxis in ovarian cancer patients before and after surgery?

Hosted by:
David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology



Featuring:
Amanika Kumar, MD, Mayo Clinic 
Laura Havrilesky, MD, Duke University